Mostrar el registro sencillo del ítem

dc.contributor.authorLopez-Huertas, Maria Rosa 
dc.contributor.authorMateos, Elena 
dc.contributor.authorSanchez-Del Cojo, Maria 
dc.contributor.authorGómez-Esquer, Francisco
dc.contributor.authorDíaz-Gil, Gema
dc.contributor.authorRodriguez‑Mora, Sara 
dc.contributor.authorLopez, Juan Antonio 
dc.contributor.authorCalvo, Enrique 
dc.contributor.authorLópez-Campos, Guillermo
dc.contributor.authorAlcamí, José 
dc.contributor.authorCoiras, Mayte 
dc.date.accessioned2018-11-30T13:50:35Z
dc.date.available2018-11-30T13:50:35Z
dc.date.issued2013-03-15
dc.identifier.citationJ Biol Chem. 2013; 288(11):7626-44es_ES
dc.identifier.issn0021-9258es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/6749
dc.description.abstractHIV-1 replication is efficiently controlled by the regulator protein Tat (101 amino acids) and codified by two exons, although the first exon (1-72 amino acids) is sufficient for this process. Tat can be released to the extracellular medium, acting as a soluble pro-apoptotic factor in neighboring cells. However, HIV-1-infected CD4(+) T lymphocytes show a higher resistance to apoptosis. We observed that the intracellular expression of Tat delayed FasL-mediated apoptosis in both peripheral blood lymphocytes and Jurkat cells, as it is an essential pathway to control T cell homeostasis during immune activation. Jurkat-Tat cells showed impairment in the activation of caspase-8, deficient release of mitochondrial cytochrome c, and delayed activation of both caspase-9 and -3. This protection was due to a profound deregulation of proteins that stabilized the mitochondrial membrane integrity, such as heat shock proteins, prohibitin, or nucleophosmin, as well as to the up-regulation of NF-κB-dependent anti-apoptotic proteins, such as BCL2, c-FLIPS, XIAP, and C-IAP2. These effects were observed in Jurkat expressing full-length Tat (Jurkat-Tat101) but not in Jurkat expressing the first exon of Tat (Jurkat-Tat72), proving that the second exon, and particularly the NF-κB-related motif ESKKKVE, was necessary for Tat-mediated protection against FasL apoptosis. Accordingly, the protection exerted by Tat was independent of its function as a regulator of both viral transcription and elongation. Moreover, these data proved that HIV-1 could have developed strategies to delay FasL-mediated apoptosis in infected CD4(+) T lymphocytes through the expression of Tat, thus favoring the persistent replication of HIV-1 in infected T cells.es_ES
dc.description.sponsorshipThis work was supported in part by Fundación para la Investigación y la Prevención del Sida en España Grant 360924/10, Spanish Ministry of Economy and Competitiveness Grant SAF2010-18388), Spanish Ministry of Health Grant EC11-285, AIDS Network Instituto del Salud Carlos III-Redes Temáticas de Investigación Cooperativa Grant RD06/0006, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness Grant Fondo de Investigaciones Sanitarias PI080752, and the Network of Excellence EUROPRISE.es_ES
dc.language.isoenges_ES
dc.type.hasVersionAMes_ES
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.meshCD4-Positive T-Lymphocytes es_ES
dc.subject.meshCaspase 3 es_ES
dc.subject.meshCaspase 8 es_ES
dc.subject.meshCaspase 9 es_ES
dc.subject.meshCytochromes c es_ES
dc.subject.meshExons es_ES
dc.subject.meshHIV-1 es_ES
dc.subject.meshHumans es_ES
dc.subject.meshJurkat Cells es_ES
dc.subject.meshMitochondria es_ES
dc.subject.meshMutagenesis, Site-Directed es_ES
dc.subject.meshNF-kappa B es_ES
dc.subject.meshOligonucleotide Array Sequence Analysis es_ES
dc.subject.meshProteome es_ES
dc.subject.meshProteomics es_ES
dc.subject.meshTransfection es_ES
dc.subject.meshfas Receptor es_ES
dc.subject.meshtat Gene Products, Human Immunodeficiency Virus es_ES
dc.subject.meshApoptosis es_ES
dc.subject.meshGene Expression Regulation es_ES
dc.titleThe presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral productiones_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution 4.0 International*
dc.identifier.pubmedID23364796es_ES
dc.format.volume288es_ES
dc.format.number11es_ES
dc.format.page7626-44es_ES
dc.identifier.doi10.1074/jbc.M112.408294es_ES
dc.contributor.funderFundación para la Investigación y la Prevención del Sida en España 
dc.contributor.funderMinisterio de Economía y Competitividad (España) 
dc.contributor.funderRETICS-Sida (RIS-ISCIII) (España) 
dc.contributor.funderMinisterio de Sanidad y Política Social (España) 
dc.contributor.funderInstituto de Salud Carlos III 
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.1074/jbc.M112.408294es_ES
dc.identifier.journalThe Journal of biological chemistryes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiología
dc.repisalud.orgCNICCNIC::Unidades técnicas::Proteómica / Metabolómicaes_ES
dc.repisalud.institucionCNICes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2010-18388es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/EC11-285es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD06/0006es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI080752es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/FI09/00347es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International
Este Item está sujeto a una licencia Creative Commons: Attribution 4.0 International